UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
___________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: October 4, 2013
(Date of earliest event reported)
BIORESTORATIVE THERAPIES, INC.
(Exact Name of Registrant as Specified in Charter)
|
Nevada
|
000-54402
|
91-1835664
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File No.)
|
(IRS Employer Identification Number)
|
|
555 Heritage Drive, Jupiter, Florida
|
33458
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (561) 904-6070
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
____
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
____
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
____
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
____
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
On October 4, 2013, the Company held its Annual Meeting of Shareholders (the “Annual Meeting”). The following is a listing of the votes cast for or withheld, and the number of broker non-votes, with respect to each nominee for director and a listing of the votes cast for and against, as well as abstentions and broker-non votes, with respect to each other matter voted upon at the Annual Meeting. The Company’s shareholders elected each of the nominees as a director, approved the Company’s executive compensation, recommended that future advisory votes on the Company’s executive compensation be held every three years and ratified the selection of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013.
|
1.
|
Election of Board of Directors:
|
|
Number of Shares
|
||||||||||||
|
For
|
Withheld
|
Broker Non-Votes
|
||||||||||
|
Mark Weinreb
|
6,915,725 | 80,137 | 1,766,923 | |||||||||
|
A. Jeffrey Radov
|
6,935,725 | 60,137 | 1,766,923 | |||||||||
|
Joel San Antonio
|
6,935,725 | 60,137 | 1,766,923 | |||||||||
2. Approval of the Company’s executive compensation:
|
For
|
6,863,712 | |||
|
Against
|
88,620 | |||
|
Abstentions
|
43,530 | |||
|
Broker Non-Votes
|
1,766,923 |
3. Frequency of future advisory votes on the Company’s executive compensation:
|
3 Years
|
5,672,375 | |||
|
2 Years
|
549,378 | |||
|
1 Year
|
770,948 | |||
|
Abstentions
|
3,161 | |||
4. Ratification of the selection of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013:
|
For
|
8,731,668 | |||
|
Against
|
10,928 | |||
|
Abstentions
|
20,189 | |||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BIORESTORATIVE THERAPIES, INC. | |||
|
Dated: October 4, 2013
|
By:
|
/s/ Mark Weinreb | |
| Mark Weinreb | |||
| Chief Executive Officer | |||